Public-registry site landscape for NCT03795428, a Pulmonary Arterial Hypertension study sponsored by PhaseBio Pharmaceuticals Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03795428 (registry record) |
| Sponsor | PhaseBio Pharmaceuticals Inc. |
| Condition(s) | Pulmonary Arterial Hypertension |
| Phase | PHASE2 |
| Listed sites | 16 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03795428 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →